Sukhatme Mayukh

President & CIO, DirectorRoivant Sciences Ltd. (ROIV) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$620K
Net Open-Market Flow
-$620K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Other(J)33K$23.09$755K18.8M
Dec 17, 2025Sell(S)27K$23.09$620K18.9M
Dec 17, 2025Option exercise(M)60K$12.68$755K18.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2025Option exercise(M)60K$01.3M

Transaction Codes

J
Other acquisition / disposition
S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-046247) within minutes of acceptance. Every field above traces to the original document. Verify it directly: